Hjem › Cirrhose › North Carolina
Cirrhose kliniske forsøg i North Carolina
6 studier for Cirrhose søger deltagere på steder i North Carolina.
Byer i North Carolina
Officiel studietekst (engelsk)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Duke University Medical Center, Durham
- Coastal Research Institute, LLC, Fayetteville
- Carolina Researche, Greenville
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Lucas Research, Inc., Morehead City
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 30. sep. 2026 · NCT07325526Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Duke Liver Center, Durham
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 28. sep. 2026 · NCT05832229National Liver Cancer Screening Trial
- University of North Carolina, Chapel Hill
RekruttererFase 4
Alder 18 til 85 · Alle køn · Opdateret 25. sep. 2026 · NCT06084234Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
- Research Site, Morehead City
- Research Site, Raleigh
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07610837Siemens Biomarker Multi-modality
- Duke University Medical Center, Durham
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 3. apr. 2026 · NCT07495332Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.